Gnosis by Lesaffre and its partner Omicron Pharmaceuticals have published a case study exploring the benefits of K2 supplementation on an individual with calciphylaxis, a condition related to poor kidney function.Calciphylaxis is characterized by ischemic skin lesions and tissue necrosis. It mainly affects people with very poor kidney function.